Vivos Therapeutics, Inc

VVOSNASDAQ · Surgical & Medical Instruments & Apparatus

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

14.5M

on 2026-06-30, from 2.73M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

$50.0M

S-3 of 2025-02-11. 2 prospectus supplements filed under it since. S-3 ↗

$3.6M

Agreement of 2025-10-24. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-08-14 is not read yet.

Cash

0.4 quarters

$1.8M on 2026-06-30 ÷ $4.3M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-06-30	Private placement	85,910	$0.582	not stated	8-K ↗
2026-04-03	Private placement	429,957	not read	$140K	8-K ↗
2025-06-13	Private placement	725,258	not read	$3.7M	8-K ↗

Also on file: $2.9M promissory note, 2026-08-31 8-K ↗